We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+9.86%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$2.45B
AUM Growth
+$411M
Cap. Flow
+$256M
Cap. Flow %
10.46%
Top 10 Hldgs %
15.35%
Holding
416
New
151
Increased
63
Reduced
54
Closed
124

Sector Composition

Rank Sector Weight
1 Industrials 14.23%
2 Financials 11.54%
3 Healthcare 10.97%
4 Consumer Discretionary 7.9%
5 Energy 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPM icon
226
Wheaton Precious Metals
WPM
$60.9B
$1.86M 0.08%
75,000
-50,000
-40% -$1.19M
VMEM
227
DELISTED
VIOLIN MEMORY, INC.
VMEM
$1.82M 0.07%
+61,831
New +$1.78M
WD icon
228
Walker & Dunlop
WD
$1.53B
$1.81M 0.07%
+113,890
New +$1.88M
MKTG
229
DELISTED
RESPONSYS INC COM STK (CA)
MKTG
$1.78M 0.07%
108,034
ISEE
230
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.78M 0.07%
+60,000
New +$1.7M
PIKE
231
DELISTED
PIKE CORPORATION COM STK (NC)
PIKE
$1.78M 0.07%
157,221
-242,843
-61% -$2.88M
RXII
232
CALL
DELISTED
GALENA BIOPHARMA INC COM
RXII
$1.78M 0.07%
780,000
+280,000
+56% +$638K
THS
233
DELISTED
Treehouse Foods
THS
$1.75M 0.07%
+26,133
New +$1.8M
SPB icon
234
Spectrum Brands
SPB
$2.07B
$1.71M 0.07%
+26,026
New +$1.59M
JCP
235
DELISTED
J.C. Penney Company, Inc.
JCP
$1.7M 0.07%
+193,100
New +$2.75M
FPRX
236
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.67M 0.07%
+127,500
New +$1.72M
SVRA icon
237
CALL
Savara
SVRA
$1.19B
$1.67M 0.07%
27,143
VNDA icon
238
Vanda Pharmaceuticals
VNDA
$302M
$1.65M 0.07%
+150,500
New +$1.61M
WWAV
239
DELISTED
The WhiteWave Foods Company
WWAV
$1.65M 0.07%
+82,462
New +$1.57M
PKT
240
DELISTED
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
$1.61M 0.07%
103,762
-40,000
-28% -$567K
MFRM
241
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
$1.59M 0.07%
+50,000
New +$1.99M
LXFT
242
DELISTED
Luxoft Holding, Inc.
LXFT
$1.59M 0.06%
60,000
GILD icon
243
Gilead Sciences
GILD
$165B
$1.56M 0.06%
24,800
-198,532
-89% -$11.9M
XLRN
244
DELISTED
Acceleron Pharma
XLRN
$1.56M 0.06%
+70,000
New +$1.51M
KDN
245
DELISTED
KAYDON CORP
KDN
$1.54M 0.06%
+43,439
New +$1.34M
QEPM
246
DELISTED
QEP MIDSTREAM PARTNERS LP UIT REPSTG LTD PARTSP INT (DE)
QEPM
$1.51M 0.06%
+66,912
New +$1.5M
BIND
247
DELISTED
BIND THERAPEUTICS INC
BIND
$1.45M 0.06%
+102,500
New +$1.48M
DFS
248
DELISTED
Discover Financial Services
DFS
$1.39M 0.06%
27,500
+12,500
+83% +$625K
WINT
249
DELISTED
Windtree Therapeutics Inc
WINT
$1.3M 0.05%
47,414
+271
+0.6% +$6.57K
RM icon
250
Regional Management Corp
RM
$303M
$1.27M 0.05%
+40,000
New +$1.13M

Similar funds

Alyeska Investment Group's Q3 2013 Portfolio in Review

As of Q3 2013, Alyeska Investment Group held 416 positions worth $2.45B, up 20% from $2.04B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Alyeska Investment Group deployed $256M of net new capital in Q3 2013, opening 151 new positions and adding to 63 existing holdings. Its largest new stake was Weatherford International plc: 1,850,370 shares worth $28.4M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $29.4M trimmed.

  • Alyeska Investment Group's largest Q3 2013 buy was Weatherford International plc: 1,850,370 shares worth $28.4M.
  • Alyeska Investment Group added most to ITT in Q3 2013, an estimated $19.5M increase.
  • Alyeska Investment Group's biggest Q3 2013 reduction was Meta Platforms (Facebook), cutting an estimated $29.4M.
  • Alyeska Investment Group fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2013, selling an estimated $21.3M.
  • Alyeska Investment Group's ten largest holdings make up 15% of its $2.45B portfolio in Q3 2013.
  • Alyeska Investment Group opened 151 new positions and closed 124 in Q3 2013.
  • Alyeska Investment Group's portfolio value rose 20% quarter-over-quarter to $2.45B.

Based on Alyeska Investment Group's 13F filing for Q3 2013, filed 14 Nov 2013.